Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Manufacturing Potency Problems Drive Rise In Recalls During 2002

Executive Summary

An increase in potency-related manufacturing problems contributed to a rise in recalls during 2002
Advertisement

Related Content

Wyeth Estrogens GMP Surveillance Will Address Dissolution Issues
Wyeth Estrogens GMP Surveillance Will Address Dissolution Issues
FDA GMP Initiative Shifts Warning Letter Review Back To Agency Centers
Drug Recalls Prompted By FDA Findings Accounted For 60% Of Total In 2000
Advertisement
UsernamePublicRestriction

Register

PS041489

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel